Kairos Pharma adjusts stock purchase price to 97% of VWAP
Kairos Pharma and Helena Global Investment modified a stock purchase agreement, reducing the purchase price from a fixed amount to a metric based on daily trading volume. This adjustment could impact Krypt's future drawdowns.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed